Literature DB >> 19298257

The anorexic agents, sibutramine and fenfluramine, depress GABA(B)-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells.

Ada Ledonne1, Luca Sebastianelli, Mauro Federici, Giorgio Bernardi, Nicola Biagio Mercuri.   

Abstract

BACKGROUND AND
PURPOSE: Nutrition is the result of a complex interaction among environmental, homeostatic and reward-related processes. Accumulating evidence supports key roles for the dopaminergic neurons of the ventral midbrain in regulating feeding behaviour. For this reason, in the present study, we have investigated the electrophysiological effects of two centrally acting anorexic agents, fenfluramine and sibutramine, on these cells. EXPERIMENTAL APPROACH: Rat midbrain slices were used to make intracellular recordings from dopaminergic neurons of the substantia nigra and the ventral tegmental area. Gamma-aminobutyric acid (GABA)-mediated synaptic transmission was assessed from the inhibitory postsynaptic potentials (IPSPs) mediated by GABA(A) and GABA(B) receptors. KEY
RESULTS: Fenfluramine and sibutramine reduced, concentration-dependently, the GABA(B) IPSPs, without affecting the GABA(A)-mediated potentials. This effect is presynaptic, as postsynaptic membrane responses induced by application of a GABA(B) receptor agonist, baclofen, were not affected by the two drugs. Furthermore, the selective 5-hydroxytriptamine 1B (5-HT(1B)) receptor antagonist, SB216641, blocked the reduction of GABA(B) IPSPs caused by fenfluramine and sibutramine, indicating that the receptor mediating this effect is 5-HT(1B). CONCLUSIONS AND IMPLICATIONS: Two anorexic agents, fenfluramine and sibutramine, induced the activation of 5-HT(1B) receptors located on presynaptic GABAergic terminals, thus reducing the release of GABA. This action can alter the strength of synaptic afferents that modify the activity of dopaminergic neurons, inducing neuronal excitation. Our results reveal an additional mechanism of action for fenfluramine and sibutramine that might contribute to reducing food intake, by influencing the pleasurable and motor aspects of feeding behaviour.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298257      PMCID: PMC2697726          DOI: 10.1111/j.1476-5381.2008.00081.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite.

Authors:  Alfonso Abizaid; Zhong-Wu Liu; Zane B Andrews; Marya Shanabrough; Erzsebet Borok; John D Elsworth; Robert H Roth; Mark W Sleeman; Marina R Picciotto; Matthias H Tschöp; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

2.  Further evidence of Ca(2+)-dependent, exocytotic-like serotonin release induced by D-fenfluramine.

Authors:  M Cinquanta; E Frittoli; T Mennini; M Gobbi
Journal:  Pharmacol Res       Date:  1997-05       Impact factor: 7.658

Review 3.  The mechanism of action of fenfluramine.

Authors:  S Garattini; W Buczko; A Jori; R Samanin
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

4.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

5.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

6.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

7.  Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.

Authors:  William S Cobb; Elizabeth D Abercrombie
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

8.  A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents.

Authors:  D J Heal; S C Cheetham; M R Prow; K F Martin; W R Buckett
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

9.  Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels.

Authors:  L E O'Dell; L H Parsons
Journal:  J Pharmacol Exp Ther       Date:  2004-06-28       Impact factor: 4.030

10.  Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.

Authors:  Stephanie L Borgland; Sharif A Taha; Federica Sarti; Howard L Fields; Antonello Bonci
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

View more
  2 in total

1.  Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.

Authors:  Mehdi Farokhnia; Mikela B Sheskier; Mary R Lee; April N Le; Erick Singley; Sofia Bouhlal; Timmy Ton; Zhen Zhao; Lorenzo Leggio
Journal:  Neuropharmacology       Date:  2018-04-14       Impact factor: 5.250

2.  Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.

Authors:  Bronwen Martin; Yu-Kyong Shin; Caitlin M White; Sunggoan Ji; Wook Kim; Olga D Carlson; Joshua K Napora; Wayne Chadwick; Megan Chapter; James A Waschek; Mark P Mattson; Stuart Maudsley; Josephine M Egan
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.